Where I see patients (2)
Selected research
-
Correction to: Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study.
Advances in therapy
-
Brodalumab: Seven-Year US Pharmacovigilance Report.
Dermatology and therapy
-
Neurocosmetics are cosmetics, which mean that they could have effects only on skin.
Clinics in dermatology